Therapeutic advances in ADPKD: the future awaits
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
https://link.springer.com/content/pdf/10.1007/s40620-021-01062-6.pdf
Reference105 articles.
1. Lanktree MB, Haghighi A, Guiard E et al (2018) Prevalence estimates of polycystic kidney and liver disease by population sequencing. J Am Soc Nephrol 29(10):2593–2600
2. Harris PC, Torres VE (2014) Genetic mechanisms and signalling pathways in autosomal dominant polycystic kidney disease. J Clin Invest 124(6):2315–2324
3. Hanaoka K, Devuyst O, Schwiebert EM et al (1996) A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol 270(1 Pt 1):C389–C399
4. Distefano G, Boca M, Rowe I et al (2009) Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol Cell Biol 29(9):2359–2371
5. Spirli C, Okolicsanyi S, Fiorotto R et al (2010) Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. Hepatology 51(5):1778–1788
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Introductory Chapter: Chronic Kidney Disease – Introductive Overview and Current Issues;Chronic Kidney Disease - Novel Insights into Pathophysiology and Treatment;2024-07-03
2. Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights;Expert Opinion on Investigational Drugs;2024-04-21
3. Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD);Nefrología (English Edition);2024-03
4. Autosomal dominante polyzystische Nierenerkrankung (ADPKD);Springer Reference Medizin;2023-12-27
5. Metabolic reprogramming: Unveiling the therapeutic potential of targeted therapies against kidney disease;Drug Discovery Today;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3